Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients
Sign Up to like & getrecommendations! Published in 2017 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1871-2
Abstract: IntroductionTo investigate prognostic factors in unresectable intrahepatic cholangiocarcinoma (ICC) therapy-naïve patients after yttrium-90 (Y-90) radioembolization (RE) therapy.Materials and MethodsBetween 2005 and 2016, 21 patients with ICC were treated with Y-90 RE only and their survival… read more here.
Keywords: prognostic factors; yttrium radioembolization; intrahepatic cholangiocarcinoma; therapy patients ... See more keywords
Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization
Sign Up to like & getrecommendations! Published in 2018 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-018-1962-8
Abstract: PurposeTo retrospectively compare early response to yttrium-90 radioembolization (Y90) according to volumetric iodine uptake (VIU) changes, Response Evaluation Criteria In Solid Tumor 1.1 (RECIST 1.1) and modified RECIST (mRECIST) in patients with intermediate-advanced hepatocellular carcinoma… read more here.
Keywords: volumetric iodine; response; yttrium radioembolization; iodine uptake ... See more keywords
Mitigation of radiation exposure during surgical hepatectomy after yttrium-90 radioembolization
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Radiological Protection"
DOI: 10.1088/1361-6498/ac09c0
Abstract: Yttrium-90 (Y-90) radioembolization for the treatment of hepatocellular carcinoma can present safety challenges when transplanting recently treated Y-90 patients. To reduce surgeons’ contact with radioactive tissue and remain within occupational dose limits, current guidelines recommend… read more here.
Keywords: yttrium radioembolization; radiation exposure; exposure; radiation ... See more keywords
Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2018 at "Pancreas"
DOI: 10.1097/mpa.0000000000001115
Abstract: Objectives An integrated protocol combining capecitibine-temozolomide with yttrium-90 radioembolization (CapTemY90) for liver-dominant grade 2 neuroendocrine tumors (NETs) was designed in the hope of achieving synergistic improvement in liver disease control with no more than additive… read more here.
Keywords: yttrium radioembolization; neuroendocrine tumors; liver dominant; liver ... See more keywords
Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
Sign Up to like & getrecommendations! Published in 2022 at "EJNMMI Physics"
DOI: 10.1186/s40658-022-00447-1
Abstract: Purpose To perform precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model and to compare extracted dose metrics to those produced from conventional PET-based dosimetry. Materials and methods… read more here.
Keywords: precision dosimetry; yttrium radioembolization; dose; dosimetry ... See more keywords
Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2024 at "Bioengineering"
DOI: 10.3390/bioengineering11020106
Abstract: The impact of yttrium 90 radioembolization (Y90-RE) in combination with immune checkpoint inhibitors (ICIs) has recently gained attention. However, it is unclear how sequencing and dosage affect therapeutic efficacy. The purpose of this study was… read more here.
Keywords: yttrium radioembolization; checkpoint inhibitors; immune checkpoint; impact yttrium ... See more keywords